ArticleCNS neuroscience & therapeutics2025
30 Hz Transcutaneous Auricular Vagus Nerve Stimulation Alleviates Abdominal Pain by Modulating EEG Activity in the α Frequency Band of the Brain.
Article in CNS neuroscience & therapeutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Bridging the gap from mechanism to clinic: a translational perspective on taVNS for gastrointestinal disorders.Frontiers in neuroscience · 2026Review
- Perioperative transcutaneous auricular vagus nerve stimulation and EEG biomarkers of sleep improvement after gynecologic laparoscopy: protocol for a randomized controlled trial.Frontiers in medicine · 2026Article
- 30 Hz Transcutaneous Auricular Vagus Nerve Stimulation Alleviates Abdominal Pain by Modulating EEG Activity in the α Frequency Band of the Brain.CNS neuroscience & therapeutics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Persistent abdominal pain (PAP) is linked to reduced prefrontal alpha oscillations, correlating with pain severity. Our study found that 30 Hz transcutaneous auricular vagus nerve stimulation (taVNS) effectively enhanced these alpha rhythms in key prefrontal regions and was selected for intervention. A 20-day 30 Hz taVNS treatment significantly alleviated pain and promoted the normalization of brain activity, demonstrating its potential as a non-pharmacological therapy for PAP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.